If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOte Ads Regulatory News (OTES)

Share Price Information for Ote Ads (OTES)

Share Price is delayed by 15 minutes
Get Live Data
11.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: $8.91b
OTES Live PriceLast checked at - London Stock Exchange

Intraday Ote Ads Share Chart

  • This share is an international stock.

FTTH plan - Shareholders Remuneration Policy

15 Dec 2021 09:50

RNS Number : 7428V
Hellenic Telecomms Organization S A
15 December 2021
 

Announcement of Regulated Information

 

Impact of the FTTH acceleration plan in the Shareholders Remuneration Policy

 

Athens, December 15, 2021 - Hellenic Telecommunications Organization S.A. ("OTE" or the "Company") announces the following:

 

The Company decided to expand and accelerate its fiber rollout coverage to reach 3 million households and businesses by 2027 with fiber-to-the home (FTTH) technology. The FTTH rollout is a major investment that will drive the country's future and secures OTE's longer term performance and competitiveness for decades to come. As a result, capital expenditure will be elevated, compared to the recent past, by an average of approximately €100 million per annum, to be funded from organic cash flows.

 

In the coming years, OTE will continue to offer to its shareholders an attractive remuneration policy, split between cash dividends and share buybacks. It is intended that the cash dividends will be normalized over this period, to avoid major fluctuations, while also accommodating any shortfall risks. To this purpose, the surpluses generated during the period 2018-2021, will be incorporated in the ordinary annual cash flows in the coming years, to support the total shareholder remuneration policy during these years.

 

In 2022, despite the incremental capital expenditure, OTE expects to deliver a total ordinary shareholder remuneration at least equal to 2021, subject to appropriate corporate approvals. The Board of Directors will determine the shareholder remuneration policy for 2022 and the following years on February 23rd 2022, together with the approval of 2021 financial statements.

 

 

The announcement is issued in accordance with (EU) Regulation No 596/2014 of the European Parliament and of the Council dated 16/4/2014, the (EU) Commission Delegated Regulation 2016/1052 dated 8/3/2016 and the Athens Exchange Rulebook (paragraph 4.1.3.14).

 

 

FOR FURTHER INFORMATION:

OTE GROUP INVESTOR RELATIONS

Τel. +30 210-6118190

E-mail: iroffice@ote.gr,

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCDKPBQCBDKOBD
Date   Source Headline
10th Mar 20238:28 amRNSPurchase of Own Shares
7th Mar 20239:30 amRNSPurchase of own shares
2nd Mar 202311:01 amRNSAnnouncement of regulated information
24th Feb 20238:57 amRNSAnnouncement - Own Share Buyback Intention
23rd Feb 20239:17 amRNSPress Release Q4'2022 Results
10th Feb 202310:31 amRNSAnnouncement of regulated information
24th Jan 202311:44 amRNSFinancial Calendar 2023
23rd Jan 202310:15 amRNSRelease Date Of Q4 2022 Financial Results
9th Dec 202212:34 pmRNSPurchase of own shares
9th Dec 202212:33 pmRNSPurchase of own shares
8th Dec 20222:55 pmRNSAnnouncement of regulated information
29th Nov 202210:25 amRNSAnnouncement of Regulated Information
29th Nov 20228:41 amRNSPurchase of own shares
25th Nov 20229:00 amRNSCancellation & Deletion of own shares
22nd Nov 20228:11 amRNSPurchase of own shares
15th Nov 20229:18 amRNSPurchase of own shares
11th Nov 20221:48 pmRNSAnnouncement of regulated information
10th Nov 20228:16 amRNS3rd Quarter Results 2022
9th Nov 20229:43 amRNSPurchase of own shares
4th Nov 20222:40 pmRNSEGM Voting Results
3rd Nov 20228:10 amRNSPurchase of own shares
1st Nov 20222:07 pmRNSEGM November 1st 2022, Resolutions
27th Oct 20228:57 amRNSPurchase of own shares
21st Oct 20228:33 amRNSPurchase of own shares
14th Oct 20222:44 pmRNSAnnouncement-write off the unclaimed dividend 2016
14th Oct 20228:27 amRNSPurchase of own shares
11th Oct 202211:23 amRNSInvitation to EGM on November 1st, 2022
10th Oct 202210:30 amRNSRelease of Q3 2022 Results
7th Oct 20229:16 amRNSPurchase of own shares
30th Sep 20228:43 amRNSPurchase of own shares
23rd Sep 20228:31 amRNSPurchase of own shares
16th Sep 20228:31 amRNSPurchase of own shares
9th Sep 202210:59 amRNSPurchase of own shares
1st Sep 20224:44 pmRNSPurchase of own shares
25th Aug 20224:27 pmRNSPurchase of Own Shares
19th Aug 20227:54 amRNSPurchase of Own Shares
12th Aug 20227:01 amRNSPurchase of own shares
5th Aug 20227:00 amRNSPurchase of Own Shares
4th Aug 20229:48 amRNS2nd Quarter and six months results
29th Jul 20227:00 amRNSPurchase of Own Shares
21st Jul 20223:59 pmRNSPurchase of Own Shares
14th Jul 20223:30 pmRNSPurchase of Own Shares
7th Jul 20224:09 pmRNSPurchase of Own Shares
7th Jul 20224:01 pmRNS€150mn loan under the Greek Recov and Res Facility
29th Jun 20224:04 pmRNSDividend Distribution of 2021
23rd Jun 20223:53 pmRNSPurchase of Own Shares
16th Jun 20224:52 pmRNSPurchase of Own Shares
16th Jun 20224:00 pmRNSBond Issuance
9th Jun 20223:57 pmRNSPurchase of Own Shares
31st May 20229:33 amRNSVoting Results of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.